On The Go
Short upright videos. Tap one to watch, then swipe for the next.
ESMO 2026
Madrid, October 23–27, 2026
HARMONi-GI1: Ivonescimab Improves Survival in Biliary Tract Cancer | ESMO 2026
Dr. Vilma Barcia
DASL-HiCaP: Darolutamida melhora a sobrevida livre de metástases no câncer de próstata | ESMO 2026
NATALEE 6-Year Update: Overall Survival Benefit With Ribociclib | ESMO 2026
Dr. Gil Morgan
INTerpath-001: Personalized mRNA Vaccine Improves Melanoma Outcomes | ESMO 2026
Dr. Mario Balsa
DeLLphi-305: Tarlatamab + Durvalumab Improves Survival in SCLC | ESMO 2026
Dr. Uğur Özkerim
TOP-1 Trial: Can We Omit Both Radiotherapy and Endocrine Therapy?
Dr. Elisabetta Bonzano
Skin Cancer Beyond the Trials: Pregnancy & Transplant Recipients | ESMO26
Dr. Mario Balsa
Can triplet combinations improve outcomes in advanced urothelial cancer?
Sara Coca Membribes